Interested in joining one of our studies? Please browse our open studies below.
QUEST-ADVANCE
The elimination of cervical cancer has been listed by the World Health Organization as a top health priority and Canada is posed to be one of the first countries to achieve this goal. Ongoing evaluation of the HPV vaccine and dosing schedule is critical to optimizing the vaccine’s cancer-eliminating potential.
Women ages 13-27 and men ages 15-20 are invited to participate in this observational study regardless of whether or not they have received the HPV vaccine. Please email questadvance@bcchr.ubc.ca to learn more.
If you are interested in joining one of our studies or
would like to be added to our contact list, click below.